Search Results

You are looking at 61 - 70 of 2,659 items for :

  • Refine by Access: Content accessible to Me x
Clear All
Full access

CLO19-059: A Systematic Review and Meta- Analysis of Randomized Controlled Trials to Evaluate the Risk of Health-Related Quality of Life Events in Patients With Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Treated With CDK 4/6 Inhibitors

Rachana Yendala, Kyaw Thein, Sriman Swarup, Anita Sultan, Somedeb Ball, Miguel Quirch, Myo H. Zaw, Yin M. Myat, and Catherine Jones

/6 activity is over expressed, which can lead to amplification or overexpression of the genes encoding for CDK 4/6 or the cyclin D, ultimately leading to endocrine therapy resistance. We undertook a systematic review and meta-analysis of randomized controlled

Full access

CLO22-036: The Role of Zoledronic Acid Administration Among Lymphoma Patients Receiving Chemotherapy: A Systematic Review

Jacqueline Agustin, Flordeluna Mesina, and Eryll Sy

than English, review papers, or on-going clinical trials. The eligible studies were reviewed in full-text independently by two authors. Methodological quality and risk of bias assessment were done. The findings from the individual studies were

Full access

Gleason Scoring at a Comprehensive Cancer Center: What’s The Difference?

Natasha C. Townsend, Karen Ruth, Tahseen Al-Saleem, Eric M. Horwitz, Mark Sobczak, Robert G. Uzzo, Rosalia Viterbo, and Mark K. Buyyounouski

have been made regarding the need for a second confirmatory pathology review (SPR) before beginning treatment. Furthermore, no reported series have examined the impact of an SPR for men receiving external-beam radiotherapy. Of the 2 series that examine

Full access

HSR20-090: Current Utilization of Genomic Testing and Barriers to Optimal Patient Care: A Targeted Literature Review

Allysen Kaminski, Jyoti Aggarwal, and Gboyega Adeboyeje

Objectives: Targeted therapy offers potential improvements in treatment costs and quality, yet its success hinges on the ability to accurately identify biomarker targets and ensure access to testing. This review aimed to understand global barriers

Full access

EPR24-109: Intentional Weight Loss and Associated Cancer Incidence Among Patients With Overweight or Obesity: A Systematic Literature Review

Chi-Yin Liao, Kristin M. Sheffield, Meredith M. Hoog, David Schapiro, Raghuvir Keni, Wambui Grace Gathirua-Mwangi, and Hong Kan

systematic literature review (SLR) was conducted to assess the association between intentional weight loss and cancer incidence, inclusive of all cancers and 13 obesity-associated cancers, from recent observational studies and clinical trials. Methods: A

Full access

HSR22-142: A Review of Lung Cancer Screening Compliance in a Federally Qualified Health Center: Uncovering Unconscious Bias

Janeen Grant-Sittol, Rani Sittol, Latoya Gayle, Sharde Mcleish, Jodi-Ann Smith, Jason Lofters, Zachary Banbury, Natasha Rastogi, and Tanganyika Barnes

center, retrospective observational study was done of patients seen at the Englewood NHCAC from January 1, 2020 to December 31, 2020. Chart review was performed using a checklist to assess adherence to 2013 screening guidelines. Comparisons were analyzed

Full access

Survivorship Care Planning: Why Is It Taking So Long?

Sarah A. Birken and Deborah K. Mayer

clearly and effectively explained.” The objective of the IOM's recommendation was to promote care coordination, communication, and record-keeping efficiency. Although there are other survivors with active disease, this review focuses on patients ending

Full access

CLO24-069: Pneumonitis Incidences in Metastatic Non–Small Cell Lung Cancer on Immunotherapy: A Systematic Review and Meta-Analysis

Sakditad Saowapa, Natchaya Polpichai, Pharit Siladech, Chalothorn Wannaphut, Manasawee Tanariyakul, Phuuwadith Wattanachayakul, and Pakin Lalitnithi

immunotherapy. Immunotherapy (checkpoint inhibitors utilization) boosts the immune system to recognize and destroy cancer cells. However, it is often associated with immune-related complications such as pneumonitis. Objective: The present review aims to

Full access

Targeting PD-L1 After Adjuvant Radiation in Subtotally Resected Primary Pineal Melanoma: A Case Report and Literature Review

Justin Famoso, Gerald Lemole, Srinath Sundararajan, and Baldassarre Stea

Primary malignant melanoma of the pineal gland is a rare disease entity, with only 24 cases reported in the literature to date. 1 Given the rarity of this malignancy, management is primarily based on case reports and literature reviews. We present

Full access

EPR23-077: Incidence and Mechanisms of Coexisting Hematological Malignancies: Chronic Lymphocytic Leukemia and Chronic Myeloid Leukemia—A Retrospective Review

Sujan Badal and Mariam Alamgir

of these two distinct hematological neoplasms have been reported in published literature, although the incidence and underlying pathogenetic mechanism of this phenomenon remains unclear. Methods: A retrospective review was performed on 47 screened